Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide (Mounjaro) is injected under the skin at one of three sites: the abdomen, the front of the thigh, or the upper arm. All three are clinically approved, and rotating between them each week is important for keeping the skin healthy. As a prescription-only medicine, tirzepatide is started only after a clinical assessment confirms it is suitable for you — a prescriber, not an automated system, makes that call. The practical guidance below reflects the NHS patient information for tirzepatide and the medicine's Summary of Product Characteristics.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The abdomen is the most commonly chosen site. You can use any area of the belly except a roughly 5 cm radius around the navel. Fatty tissue is plentiful there, absorption is consistent, and most people find it easy to manage on their own. It is a reliable starting point when you are getting used to the pen.
The front of the thigh is the second option. Use the outer-facing or front-facing surface, roughly the middle third of the thigh, not the inner thigh, which is closer to blood vessels. If you want more detail on using this site, there is a full walkthrough on injecting tirzepatide into the thigh, including which part of the leg to target and how to pinch the skin correctly.
The upper arm can be used, but it is the trickiest site to reach on your own, most people need someone to help. If you are self-injecting, the outer, fleshy part of the upper arm is the target area. Keep well away from the shoulder joint and the inner arm. If self-injection at this site is uncomfortable or awkward, the abdomen or thigh is usually the better solo choice.
All three sites give similar drug absorption in clinical practice. The choice is mostly about practicality and personal comfort, both reasonable things to factor in.
Clean the chosen patch of skin with an alcohol swab and let it dry fully before you inject. Wet skin stings more, and moisture can affect the seal around the injection site. Once dry, pinch a fold of skin gently, insert the KwikPen at the angle described in your Patient Information Leaflet, and press the button slowly and fully until you hear the click and see the injection window change. Hold the pen in place for a few seconds before removing it.
Inject into subcutaneous fat (the soft layer beneath the skin) not into muscle. Muscle injections are more painful and can affect how the medicine is absorbed. If you are very lean and have little subcutaneous fat at a given site, discuss this with your prescriber, who may advise on technique or an alternative site. The step-by-step injection guide covers the full technique, including what to do if you miss a click or the pen does not feel right.
Dispose of the needle immediately after use in an approved sharps container. Used needles must never go in household recycling or general waste.
Rotation is the habit that protects your skin over months of weekly injections. Injecting the same small patch repeatedly causes lipodystrophy, the tissue becomes lumpy or hardened, and absorption of the medicine through that area becomes unreliable. That means the dose you think you are getting may not be the dose your body receives.
A simple rotation rule: change the main site each week (abdomen one week, thigh the next, for example), and within each site, move at least 1–2 cm from where you injected last time. Keeping a brief mental note or marking a small diagram can help if you find it hard to remember. Many people settle into a pattern after a few weeks, that is fine, as long as the pattern genuinely moves around.
Your prescriber or the Mounjaro injection overview can answer questions about rotation if a particular site is causing you trouble. You can also read more about the broader treatment on the Mounjaro treatment page.
Never inject into skin that is bruised, tender, actively irritated, infected, or scarred. These areas absorb medicine poorly and carry a higher risk of local complications. Similarly, avoid any site where you have noticed the skin becoming lumpy or uneven from previous injections, let that area rest and recover.
Tirzepatide should be stored in the fridge (2–8°C) right up until you are ready to use it. If you have questions about keeping the pen safe at home or away, the tirzepatide storage guide covers fridge rules, travel, and the limited window for room-temperature use. For timing (what day and time of week to inject, and what to do if a dose is late) the guide on when to inject tirzepatide is the right place to look.
If you notice a site reaction that does not settle within a day or two, swelling, redness spreading beyond the injection point, or any sign of infection, contact your prescriber. Most injection-site reactions are mild and temporary, but persistent or worsening ones deserve a clinical eye.
If you are considering tirzepatide and want to understand your options, the free consultation at nume connects you with a GPhC-registered Independent Prescriber who reviews your case the same day. No waiting list. Starting the conversation costs nothing.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.